Sands Capital Management
TXG icon

Sands Capital Management’s 10x Genomics TXG Stock Holding History

Sands Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,542
Closed -$180K – 78
2024
Q4 		$180K Hold
12,542
– – ﹤0.01% 71
2024
Q3 		$283K Sell
12,542
-2,322,359
-99% -$48M ﹤0.01% 67
2024
Q2 		$45.4M Sell
2,334,901
-1,048,240
-31% -$27.4M 0.13% 58
2024
Q1 		$127M Sell
3,383,141
-207,004
-6% -$9.09M 0.36% 45
2023
Q4 		$201M Sell
3,590,145
-395,325
-10% -$17.2M 0.61% 39
2023
Q3 		$164M Sell
3,985,470
-134,799
-3% -$7.01M 0.56% 41
2023
Q2 		$230M Buy
4,120,269
+382,501
+10% +$20.7M 0.71% 39
2023
Q1 		$209M Buy
3,737,768
+530,985
+17% +$24.8M 0.69% 39
2022
Q4 		$117M Sell
3,206,783
-184,394
-5% -$6.03M 0.44% 48
2022
Q3 		$96.6M Sell
3,391,177
-135,701
-4% -$5.17M 0.36% 50
2022
Q2 		$160M Buy
3,526,878
+325,484
+10% +$16.9M 0.55% 40
2022
Q1 		$244M Buy
3,201,394
+1,537,427
+92% +$134M 0.56% 40
2021
Q4 		$248M Buy
+1,663,967
New +$255M 0.46% 42

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sands Capital Management's TXG Position: Q1 2025 in Review

Sands Capital Management sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 12,542 shares — an estimated $180K sold.

Sands Capital Management first reported a position in TXG in Q4 2021 and held it in 13 quarters. The position peaked at $248M in Q4 2021. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • Sands Capital Management reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
  • Sands Capital Management sold 12,542 10x Genomics shares in Q1 2025, an estimated $180K.
  • Sands Capital Management first reported a position in 10x Genomics in Q4 2021 and held it in 13 quarters.
  • Sands Capital Management's 10x Genomics position peaked at $248M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on Sands Capital Management's 13F filing for Q1 2025, filed 14 May 2025.